Patents by Inventor Suzette Girgis

Suzette Girgis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11952426
    Abstract: Methods of treating cancers using a BCMAxCD3 bispecific antibody are described.
    Type: Grant
    Filed: May 11, 2021
    Date of Patent: April 9, 2024
    Assignee: Janssen Biotech, Inc.
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin
  • Publication number: 20220373550
    Abstract: Methods of monitoring progression of multiple myeloma or plasmacytoma, particularly relapsed or refractory multiple myeloma, are described. Also described are methods of treating or determining response to a treatment for multiple myeloma or plasmacytoma in a subject.
    Type: Application
    Filed: May 11, 2022
    Publication date: November 24, 2022
    Inventors: Kodandaram Pillarisetti, Suzette Girgis, Jenna Goldberg, Shun Xin Wang Lin
  • Publication number: 20220177584
    Abstract: Methods of treating a hematological malignancy using a GPRC5D×CD3 bispecific antibody are described. The hematological malignancy can be a relapsed or refractory multiple myeloma, and the GPRC5D×CD3 bispecific antibody can be talquetamab.
    Type: Application
    Filed: September 16, 2021
    Publication date: June 9, 2022
    Inventors: Suzette Girgis, Jenna Goldberg, Brandi Hilder, Xuewen Ma, Jeffery Russell, Raluca Verona, Shiyi Yang, Kodandaram Pillarisetti
  • Publication number: 20220041742
    Abstract: Methods of treating cancers using a BCMA×CD3 bispecific antibody are described.
    Type: Application
    Filed: May 11, 2021
    Publication date: February 10, 2022
    Inventors: Homer Adams, Arnob Banerjee, Suzette Girgis, Jenna Goldberg, Tara Stephenson, Raluca Verona, Shun xin Wang lin